Medical marijuana is now Schedule III. Here's what the federal reclassification actually changes for patients, clinicians, and states (it’s not legalization).

This review on IBD and depression explains how the gut-brain loop may drive both inflammation and mood symptoms (and how the gut and brain speak to each other in both directions).

Podcast recap on chronic pain, the nervous system, Pain Reprocessing Therapy, and how medical cannabis may fit into a more individualized treatment plan.

A UC Berkeley study found awe had the most reliable link to lower IL-6 among seven positive emotions.

A study published in JAMA in March of 2026 says psychedelics are no better than antidepressants for depression. Here’s why the headline misses key context on side effects, duration, and healing.

Ketamine dosing explained: IV, IM, intranasal, and oral routes compared: bioavailability, clinical research, and how dosing decisions are made.

New JAMA study: ~100 minutes of daily walking (no matter the speed) is linked to lower chronic low back pain risk and better longevity outcomes.

A summary of our 3-patient case series in Frontiers in Pain Research: low-dose ketamine plus PRT/somatic tracking, IFS/EMDR, breathwork & movement.

The Window of Tolerance explains how much stress and emotion your body can handle before tipping into overwhelm or shutdown.

Your body budget tracks energy like a bank account. When it runs low, your mood and health suffer.

Stanford Medicine' talk summary: why women’s pain differs across life stages, the role of hormones/nervous system, and practical, evidence-informed care takeaways.

Congress ended the recent government shutdown with a bill (H.R. 5371) that also quietly rewrites the rules for hemp in a 1-year phase-in.

Insights from Harvard’s Interdisciplinary Pain & Headache Rounds and how they inform an evidence-based care pathway.

Reframing “treatment-resistant depression” as “treatment nonresponse” opens new pathways for hope and healing.

FDA approves Tonmya, a first-in-class non-opioid for fibromyalgia pain, sleep issues, and fatigue. A new treatment option is here.

How inflammation skews the kynurenine pathway — and how ketamine and NAD+ therapy may protect and restore mental health & energy.

Pain Reprocessing Therapy retrains the brain to interpret pain differently. Learn its origins, research, and why we believe in it.

Science-based ADHD focus guide from Huberman Lab: meds, OTC supplements, and behavioral tools to improve attention and focus.

Takeaways & insights from Glennon Doyle’s most recent book, We Can Do Hard Things.

A conversation with Claudia from the Longevity & Lifestyle Podcast about medical cannabis, ketamine therapy, chronic pain, and more.